Characterization of medicinal compounds confined in porous media by neutron vibrational spectroscopy and first-principles calculations: A case study with ibuprofen

Pharmaceutical Research

Volumn 29, Issue 9, 2012, Pages 2432-2444

  Qian, Ken K ^a   Zhou, Wei ^a   Xu, Xiaoming ^b   Udovic, Terrence J ^a  

^a NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Amorphization; First principles calculations; Mesoporous; Neutron vibrational spectroscopy; Silicon dioxide

Indexed keywords

ADSORBENT; ATTAPULGITE; CARBOXYLIC ACID; HYDROXYL GROUP; IBUPROFEN; SILICON DIOXIDE;

ADSORPTION KINETICS; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DESORPTION; DRUG FORMULATION; DRUG MIXTURE; DRUG STRUCTURE; HYDROGEN BOND; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MOLECULAR INTERACTION; NEUTRON VIBRATIONAL SPECTROSCOPY; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SPECTROSCOPY; STRUCTURE ANALYSIS; SURFACE PROPERTY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; IBUPROFEN; MODELS, MOLECULAR; NEUTRONS; POWDER DIFFRACTION; SPECTRUM ANALYSIS;

EID: 84866731803     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-012-0771-z     Document Type: Article

References (31)

1. Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci. 1997;86:1-12.
2. Yu L. Amorphous pharmaceutical solids: Preparation, characterization and stabilization. Adv Drug Deliv Rev. 2001;48:27-42.
3. Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti RA, Rouquerol J, et al. Reporting physisorption data for gas/solid systems with special reference to the determination of surface area and porosity. Pure Appl Chem. 1985;57:603-19.
4. Mellaerts R, Aerts CA, Humbeeck JV, Augustijns P, Van den Mooter G, Martens JA. Enhanced release of itraconazole from ordered mesoporous SBA-15 silica materials. Chem Commun. 2007;1375-77.
5. Qian KK, Bogner RH. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J Pharm Sci. 2012;101:444-63.
6. QianKK, Bogner RH. Spontaneous crystalline-to-amorphous phase transformation of organic ormedicinal compounds in the presence of porous media. Part 1: Thermodynamics of spontaneous amorphization. J Pharm Sci. 2011;100:2801-15.
7. Qian KK, Suib SL, Bogner RH. Spontaneous crystalline-toamorphous phase transformation of organic or medicinal compounds in the presence of porous media. Part 2: Amorphization capacity and mechanisms of interaction. J Pharm Sci. 2011; 100:4674-86.
8. Qian KK, Wurster DE, Bogner RH. Spontaneous crystalline-toamorphous phase transformation of organic or medicinal compounds in the presence of porous media. Part 3: Effect of moisture. Pharmaceutical Research (In press, doi:10.1007/s11095-012-0734-4).
9. Klafter J, Drake JM. Molecular dynamics in restricted geometries. New York: Wiley; 1989.
10. Mellaerts R, Jammaer JAG, Van SpeybroeckM, Chen H, Humbeeck JV, Augustijns P, et al. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: A case study with itraconazole and ibuprofen. Langmuir. 2008;24:8651-9.
11. Bras AR, Merino EG, Neves PD, Fonseca IM, Dionisio M, Schonhals A, et al. Amorphous ibuprofen confined in nanostructured silica materials: A dynamical approach. J Phys Chem C. 2011;115:4616-23.
12. Iler RK. The chemistry of silica. New York: Wiley; 1979.
13. Vansant EF, Van der Voort P, Vrancken KC. Characterization and chemical modification of the silica surface. Amsterdam: Elsevier; 1995.
14. Zhuravlev LT. The surface chemistry of amorphous silica. Zhuravlev model. Colloids Surf A Physicochem Eng Aspects. 2000;173:1-38.
15. Colthup NB, Daly LH, Wiberley SE. Introduction to infrared and Raman spectroscopy. Boston: Academic; 1990.
16. Mitchell PCH. Vibrational spectroscopy with neutrons with applications in chemistry, biology, material science and catalysis. New Jersey: World Scientific; 2005.
17. Willis BTM, Carlile CJ. Experimental neutron scattering. Oxford: Oxford University Press; 2009.
18. Certain trade names and company products are identified in this paper in order to specify adequately the experimental procedure Such identification does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the instruments, materials or suppliers identified are necessarily the best available for the purpose.
19. Perlovich GL, Kurkov SV, Hansen LK, Bauer-Brandl A. Thermodynamics of sublimation, crystal lattice energies, and crystal structures of racemates and enantiomers: Ibuprofen. J Pharm Sci. 2004;93:654-66.
20. Azais T, Tourne-Peteilh C, Aussenac F, Baccile N, Coelho C, Devoisselle J-M, et al. Solid-state NMR study of ibuprofen confined in MCM-41 material. Chem Mater. 2006;18:6382-90.
21. Barrett EP, Joyner LG, Halenda PP. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J Am Chem Soc. 1951;73:373-80.
22. Udovic TJ, Brown CM, Leao JB, Brand PC, Jiggetts RD, Zeitoun R, et al. The design of a bismuth-based auxiliary filter for the removal of spurious background scattering associated with filteranalyzer neutron spectrometers. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 2008;588:406-13.
23. Yildirim T. Structure and dynamics from combined neutron scattering and first-principles studies. Chem Phys. 2000;261:205-16.
24. Barone V, Casarin M, Forrer D, Pavone M, Sambi M, Vittadini A. Role and effective treatment of dispersive forces in materials: Polyethylene and graphite crystals as test cases. J Comput Chem. 2009;30:934-9.
25. Shankland N, Wilson CC, Florence AJ, Cox PJ. Refinement of ibuprofen at 100K by single-crystal pulsed neutron diffraction. Acta Crystallogr Sect C Cryst Struct Commun. 1997;C53:951-4.
26. Gregg SJ, Sing KSW. Adsorption, surface area, and porosity. London: Academic; 1967.
27. Glatter O, Kratky O. Small angle X-ray scattering. London: Academic; 1982.
28. Hailu SA, Bogner RH. Effect of the pH grade of silicates on chemical stability of coground amorphous quinapril hydrochloride and its stabilization using pH-modifiers. J Pharm Sci. 2009;98:3358-72.
29. Hailu SA, Bogner RH. Solid-state surface acidity and pH-stability profiles of amorphous quinapril hydrochloride and silicate formulations. J Pharm Sci. 2010;99:2786-99.
30. Hailu SA, Bogner RH. Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates. J Pharm Sci. 2011;100:1503-15.
31. Yoshioka S, Aso Y. Correlations between molecular mobility and chemical stability during storage of amorphous pharmaceuticals. J Pharm Sci. 2007;96:960-81.